Close Menu

clinical trial

Interleukin will provide its genetic tests for inflammatory and metabolic diseases for a study directed at a cardiovascular disease drug in development.

Roche stopped studying the drug in pre-dementia Alzheimer's patients but is continuing to investigate it in mild dementia patients by tracking cerebral spinal fluid biomarkers.

The Afinitor-containing regimen boosted median progression-free survival by seven months in women with HER2-positive, hormone receptor-negative breast cancer.

The Salt Lake City-based MDx firm has initiated a clinical trial for its sample-to-result Staph identification/resistance test.

Interim data showed 40 percent of patients with a DNA repair signature experienced tumor shrinkage when treated with the drug.

BioMérieux's BioFire Diagnostics subsidary and Cepheid sponsored presentations at the American Association for Molecular Pathology annual meeting in which clinical users shared preliminary data on highly anticipated products from the companies.

NEW YORK (GenomeWeb) – Foundation Medicine today said that it has signed a licensing deal with WuXi PharmaTech, enabling that firm to offer Foundation Medicine's genomic profiling technology to companies conducting clinical trials in China.

NEW YORK (GenomeWeb) – Benitec Biopharma said this week that laboratory data on the first patient dosed in its Phase I/IIa trial its expressed RNAi treatment for hepatitis C indicate that the drug is safe and well tolerated.

NEW YORK (GenomeWeb) – Sangamo BioSciences today said that the California Institute for Regenerative Medicine has awarded $5.6 million grant to researchers at City of Hope to develop an HIV/AIDS therapeutic based on Sangamo's zinc finger nuclease genome editing technology.

NEW YORK (GenomeWeb News) – By combing through drugs that have already undergone the approval process, researchers led by Stanford University's Julien Sage found that two therapies usually prescribed to treat depression may also help combat small-cell lung cancer, as they reported in Cancer D

Pages

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.